Major deals boost CT biopharma sector after period of closings and layoffs
A pharma giant expresses interest in a Stamford biotech company after striking a deal worth up to $1.3 billion for a New ...
pharmaphorum21h
Merck KGaA's ATR cancer drug cleared for further trials after phase 1 trial success
Merck KGaA’s ATR inhibitor cancer drug has been cleared for further clinical trials after it showed encouraging activity in a phase 1 study. Short for ataxia telangiectasia and Rad3-related ...
pharmaphorum21h
MeiraGTx plans to take Parkinson's gene therapy into phase 3
Shares rose almost 15% on the Parkinson's data. Merck KGaA has acknowledged that it is in talks to buy US cancer SpringWorks, but cautioned there is no guarantee a deal will be forthcoming.
Key deals this week: Papa John's, Spirit Airlines, Novartis, Banco Santander and more
From consumer to healthcare, here's a list of key deals reported this week: Papa John's (NASDAQ:PZZA) jumped 18% on a report that a Qatari-backed investor is considering a takeover of the pizza chain.